Neval Ozkaya

Neval Ozkaya

National Institutes of Health - Bethesda / United States
Medical and Health Sciences / Pathology
AD Scientific Index ID: 4388292
person_outline Neval Ozkaya's MOST POPULAR ARTICLES
1-) Efficacy of MEK inhibition in patients with histiocytic neoplasmsEL Diamond, BH Durham, GA Ulaner, E Drill, J Buthorn, M Ki, L Bitner, ...Nature 567 (7749), 521-524, 20191812019
2-) A somatic mutation in erythro-myeloid progenitors causes neurodegenerative diseaseE Mass, CE Jacome-Galarza, T Blank, T Lazarov, BH Durham, N Ozkaya, ...Nature 549 (7672), 389-393, 20171452017
3-) The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohortN Ozkaya, MK Rosenblum, BH Durham, JD Pichardo, O Abdel-Wahab, ...Modern Pathology 31 (4), 581-597, 2018942018
4-) High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosisM Papo, EL Diamond, F Cohen-Aubart, JF Emile, D Roos-Weil, N Gupta, ...Blood, The Journal of the American Society of Hematology 130 (8), 1007-1013, 20171282017
5-) Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cellsBH Durham, D Roos-Weil, C Baillou, F Cohen-Aubart, A Yoshimi, ...Blood, The Journal of the American Society of Hematology 130 (2), 176-180, 20171202017